Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Herantis Pharma phase 1b data readout

By Inderes
Herantis Pharma

Herantis Pharma announced positive topline data for HER-096 in Phase 1b trial for people living with Parkinson’s disease. Trial met all primary and secondary endpoints establishing a strong foundation to Phase 2.

Herantis management will host a webcast October 8th, at 13:00 EEST. The webcast will be held in English, and there will be a Q&A session in the end of the webcast. The questions are asked to be submitted in English.

Stay up to date
Investor events

Recent videos

HCA Morgenbørs 20/01 - Vi ser ind i en røde europæiske futures på dag 2 af EU vs. USA
20.01.2026, 09.21 GomSpace Group
GomSpace - Strategic direction & Q&A
19.01.2026, 14.00 GomSpace Group
HCA Morgenbørs 19/01 - Større udsalg i danske aktiver efter genåbnet toldkrig mellem EU og USA
19.01.2026, 09.20 Genmab
AKTIER MED FRIIS - UGE 3 2026
16.01.2026, 12.00
B&O – Præsentation af Q2 2025/26 resultater
16.01.2026, 10.00 Bang & Olufsen
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.